Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Both Alzheimer's disease and senile dementia of the Alzheimer type (AD/SDAT) are progressive dementias characterized neuropathologically by the presence in the cerebral cortex of numerous neurofibrillary tangles and neuritic plaques. We use the abbreviation AD/SDAT to denote all such cases, irrespective of age of onset. Studies of neurotransmitter-related parameters in autopsied brain tissues from patients with AD/SDAT have, to date, been confined to five putative transmitter systems. Acetycholine-releasing neurones seem to be most markedly and consistently affected, as judged by the extensive reductions in choline acetyltransferase (ChAT) and acetylcholinesterase activities that have been reported. Despite numerous studies, there is no consistent evidence for the involvement of neurones releasing dopamine, noradrenaline, serotonin, or gamma-aminobutyric acid in AD/SDAT, nor for loss of muscarinic cholinergic receptors. Thus, the involvement of cholinergic neurones in AD/SDAT seems to be specific. However, the possible involvement of neurones using other chemicals as transmitters has yet to be explored. The recent recognition of the existence of so-called 'peptidergic neurones' in the mammalian brain (for review see ref. 8) and the availability of radioimmunoassay (RIA) techniques for studying these peptides, have led us to begin a systematic investigation of neuropeptides in autopsied brain tissue from cases of AD/SDAT, and from neurologically normal individuals. We report here results obtained with a RIA for somatostatin, showing that somatostatin-like immunoreactivity in the cerebral cortex is reduced in tissue from AD/SDAT patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Aβ not only affects intracellular vesicular trafficking but could also affect primary cilia function directly or indirectly via its cognate binding receptors such as LRP1 [15, 50, 75].”
From Abnormal accumulation of extracellular vesicles in hippocampal dystrophic axons and regulation by the primary cilia in Alzheimer's disease (2023) · cites this paper as [15]
In the citing paper
“In addition, SST administration has been shown to be effective in improving cognitive impairment in AD patients [12, 15].”
From Abnormal accumulation of extracellular vesicles in hippocampal dystrophic axons and regulation by the primary cilia in Alzheimer's disease (2023) · cites this paper as [15]
In the citing paper
“Dysfunctional SOMs have been identified as a hallmark of AD, and loss of SOMs in the cortex is associated with AD pathologies [10, 15, 65].”
From Abnormal accumulation of extracellular vesicles in hippocampal dystrophic axons and regulation by the primary cilia in Alzheimer's disease (2023) · cites this paper as [15]
In the citing paper
“Additionally, AD patients have a specific loss of somatostatin-positive interneurons in the cortex [94] and hippocampus [95].”
From Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer’s disease (2019) · cites this paper as [94]
Citations
Cites
Hökfelt, T., Johansson, O., Ljungdahl, Å., Lundberg, J. M., & Schultzberg, M. (1980) · Nature · doi:10.1038/284515a0 · Cited by 1,547
NECROPSY EVIDENCE OF CENTRAL CHOLINERGIC DEFICITS IN SENILE DEMENTIA
Perry, E., Perry, R., Blessed, G., & Tomlinson, B. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91780-9 · Cited by 1,069
Neurotransmitter-related enzymes in senile dementia of the alzheimer type
Davies, P. (1979) · Brain Research · doi:10.1016/0006-8993(79)90336-6 · Cited by 634
Self-citationThe Prevalence and Malignancy of Alzheimer Disease: A Major Killer
Katzman, R. (1976) · Archives of Neurology · doi:10.1001/archneur.1976.00500040001001 · Cited by 619
Self-citationDementia of the Alzheimer Type
Terry, R. D., & Davies, P. (1980) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.03.030180.000453 · Cited by 529
Self-citationPrevalence and Malignancy of Alzheimer Disease
Lijtmaer, H., Fuld, P. A., & Katzman, R. (1976) · Archives of Neurology · doi:10.1001/archneur.1976.00500040088017 · Cited by 517
Self-citationNEOCORTICAL CHOLINERGIC NEURONS IN ELDERLY PEOPLE
White, P., Goodhardt, M. J., Keet, J. P., Hiley, C. R., Carrasco, L. H., Williams, I. E. I., & Bowen, D. M. (1977) · The Lancet · doi:10.1016/s0140-6736(77)92114-6 · Cited by 489
Davies, P., & Verth, A. H. (1977) · Brain Research · doi:10.1016/0006-8993(77)90758-2 · Cited by 313
Self-citationRadioimmunoassay for GH-Release Inhibiting Hormone
Arimura, A., Sato, H., Coy, D. H., & Schally, A. V. (1975) · Experimental Biology and Medicine · doi:10.3181/00379727-148-38631 · Cited by 302
Research works printed but not linked: 1
- Wisniewski, H. M. & Terry, R. D. in Neurobiology of Aging (eds Terry, R. D. & Gershon, S.) 265–280 (Raven, New York, 1976).
Cited by
Items 801–889 of 889
Research in Alzheimer's disease: A progress report
Moss, M. B. (1988) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331758800300408 · Cited by 2
López-Sañudo, S., & Arilla, E. (1993) · Brain Research · doi:10.1016/0006-8993(93)91031-m · Cited by 1
Functional Cholinergic Receptor Sensitivity: The Role of Drug Probes
Sunderland, T., Molchan, S. E., Vitiello, B., Martínez, R. A., & Martin, A. D. (1991) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4899-6738-1_20 · Cited by 1
Neuropeptides in Human Aging and Dementia
Rossor, M. N. (1985) · Springer eBooks · doi:10.1007/978-1-4612-5058-6_10 · Cited by 1
Neuroendocrinology and Brain Peptides An Emerging New Frontier in Neurobiology
Martin, J. B. (1984) · Springer eBooks · doi:10.1007/978-1-4684-4529-9_2 · Cited by 1
KING, K. B., & Willoughby, J. O. (1985) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1985.tb122832.x · Cited by 1
Changes of the Neuroendocrine System in Alzheimer-type Dementia
Kiuchi, Y., Parvez, H. S., Parvez, S., & Yasuhara, H. (1992) · doi:10.1007/978-1-349-12275-2_7 · Cited by 1
Chan‐Palay, V. (1988) · Springer eBooks · doi:10.1007/978-1-4684-5502-1_11 · Cited by 1
Pascall, J. C., Borthwick, N. M., Curtis, A., Lyons, V., & Yates, C. M. (1986) · Springer eBooks · doi:10.1007/978-1-4684-5131-3_38 · Cited by 1
Poulakos, J. J., Arendash, G. W., Millard, W. J., Sjak-Shie, N. N., & Meyer, E. M. (1989) · Advances in behavioral biology · doi:10.1007/978-1-4684-5727-8_23 · Cited by 1
Molecular Approaches to Human Neurological Diseases and Their Animal Models
Price, D. L., Hoffman, P. N., Altschuler, R. J., Koo, E. H., Whitehouse, P. J., Griffin, J. W., Kitt, C. A., Cork, L. C., Powers, R. E., Walker, L. C., et al. (1986) · Springer eBooks · doi:10.1007/978-1-4615-9486-4_10 · Cited by 1
Drachman, D. A., & Swearer, J. M. (1990) · Foundations of neurology · doi:10.1007/978-1-4613-1495-0_23 · Cited by 1
Jinks, M. J., & Fuerst, R. H. (1992) · Palgrave Macmillan UK eBooks · doi:10.1007/978-1-349-13175-4_79 · Cited by 1
Early Stages of Late Onset Alzheimer's Disease
Forssell, L. G., Eriksson, H., & Forssell, L. G. (1989) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1989.tb04877.x · Cited by 1
Trophic Factors and Neurologic Disease
Appel, S. H., Tomozawa, Y., & Bostwick, J. R. (1986) · Advances in behavioral biology · doi:10.1007/978-1-4613-2179-8_10 · Cited by 2
Strittmatter, M., Strubel, D., Reuner, C., Kuntzmann, F., & Cramer, H. (1989) · Journal of Neural Transmission - Parkinsons Disease and Dementia Section · doi:10.1007/bf02312297 · Cited by 1
Influence of Gangliosides and Nerve Growth Factor on the Plasticity of Forebrain Cholinergic Neurons
Cuello, A. C., Maysinger, D., Garofalo, L., Tagari, P. C., Stephens, P. H., Pioro, E. P., & Piotte, M. (1987) · Springer eBooks · doi:10.1007/978-1-4684-5415-4_7 · Cited by 1
Knowles, S. J., Holter, M. C., Li, G., Bjorklund, G. R., Rees, K. P., Martinez-Fuentes, J. S., Nishimura, K. J., Afshari, A. E., Fry, N., Stafford, A. M., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.08.02.502073 · Cited by 1
“A loss of SST protein has been seen in a number of other neuropathological 475 conditions, but has not been directly assessed in conditions characterized by reduced ERK1/2 476 signaling (Davies et al., 1980; Fee et al., 2017; Pantazopoulos et al., 2017; Peng et al., 2013; 477 Robbins et al., 1991; Sun et al., 2020; Tr…”
BackgroundAlterations in Neuropeptide Systems in Alzheimer’s Disease
Cook, L. L., Bissette, G., & Nemeroff, C. B. (1990) · Springer eBooks · doi:10.1007/978-3-642-74034-3_53 · Cited by 1
Emson, P. C., Arai, H., & Rossor, M. N. (1987) · Springer eBooks · doi:10.1007/978-3-642-72729-0_2 · Cited by 1
Somatostatin-Dopamine Interactions in the Rat Striatum
Radke, J. M., Martin-Iverson, M. T., & Vincent, S. R. (1987) · Advances in behavioral biology · doi:10.1007/978-1-4684-5347-8_6 · Cited by 1
Shaffer, L. M., Ting, S., & Dokas, L. A. (1992) · Advances in behavioral biology · doi:10.1007/978-1-4615-3432-7_7
Shah, A. B., Shah, N. S., Morgan, D. W., & Donald, A. G. (1984) · Springer eBooks · doi:10.1007/978-1-4684-4529-9_1 · Cited by 1
Classical and Modern Neuropathological Approaches to Alzheimer’s Disease
Price, D. L., Struble, R. G., Cork, L. C., Whitehouse, P. J., Kitt, C. A., & Troncoso, J. C. (1986) · Springer eBooks · doi:10.1007/978-3-642-70007-1_11
Childers, S. R. (2000) · Wiley eBooks · doi:10.1002/0471238961.0218010903080912.a01
Cognitive Enhancers and Treatments for Alzheimer's Disease
Devanand, D. P. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch109
CONTRIBUTION OF SOMATOSTATIN DEFICITS AND EIF2 SIGNALING TO ANXIETY/DEPRESSIVE-LIKE BEHAVIORS
Lin, L. (2014) · D-Scholarship@Pitt (University of Pittsburgh)
Therapeutic strategy by manipulating some protease activities for Alzheimer's disease
Iwata, N., Higuchi, M., & Saido, T. C. (2008) · Folia Pharmacologica Japonica · doi:10.1254/fpj.131.320
Cortical and subcortical dementia
Agid, Y., & Ruberg, M. (1984) · Annals of Neurology · doi:10.1002/ana.410150522
Failure of carbachol to influence the release of somatostatin from slices of rat cerebral cortex
Boakes, R. J., & COURT, J. A. (1986) · Brain Research · doi:10.1016/0006-8993(86)91387-9
Winkelmann, E., Lüth, H., Dramm, P., Funk, R. H. W., & Fehrmann, P. (1995) · Annals of Anatomy - Anatomischer Anzeiger · doi:10.1016/s0940-9602(11)80087-7
Analysis and utilization of beta‐amyloid degradation system
Saido, T. C. (2004) · Psychogeriatrics · doi:10.1111/j.1479-8301.2003.00027.x
Development of Memory‐Enhancing Agents in the Treatment of Alzheimer's Disease
Abernethy, D. R. (1987) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1987.tb02298.x
THERAPEUTIC PROGRESS—REVIEW XVIII ALZHEIMER'S DISEASE
Kendall, M. J., Chellingsworth, M., & Main, A. (1985) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.1985.tb00931.x
Cardoso, A. (2011) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/sc5e-2g25
AN IMMUNOCYTOCHEMICAL STUDY OF THE SOMATOSTATINERGIC NERVOUS SYSTEM
Shoji, M. (1989) · Kitakantou igaku/Kitakantō Igaku · doi:10.2974/kmj1951.39.447
NAKAMURA, S. (1989) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.78.1709
Neurobiological Probes for Specific Constituents of Senile Plaques in Aging and Alzheimer’s Disease
Price, D. L., Struble, R. G., Kitt, C. A., Cork, L. C., Walker, L. C., Casanova, M. F., & Powers, R. E. (1986) · Springer eBooks · doi:10.1007/978-1-4613-2199-6_89
Delirium and Dementia (Organic Brain Syndromes)
Coffey, C. E., & Massey, E. W. (1984) · Elsevier eBooks · doi:10.1016/b978-0-409-95151-6.50014-6
Dementia in Middle and Late Life
Scholtz, C. L. (1988) · Current topics in pathology · doi:10.1007/978-3-642-71353-8_4
Alterations of neuropeptides in MPTP-treated mouse brain
Kawata, M. (1991) · Okayama Igakkai Zasshi (Journal of Okayama Medical Association) · doi:10.4044/joma1947.103.1-2_105
Tajrine, D. (1996) · Library and Archives Canada (Government of Canada) · doi:10.82308/54483
Endocrinology and the psychiatrist
BREATHNACH, C. S. (1993) · Irish Journal of Psychological Medicine · doi:10.1017/s079096670001301x
“In the cerebral cortex of patients with Alzheimer's disease there is a marked reduction of the concentration of SRIF (30). and of SRIF-specific mRNA (31).”
BackgroundInfluentialERP-based Detection of Brain Pathology in Rat Models for Preclinical Alzheimer's Disease
Nouriziabari, S. B. (2016) · TSpace (University of Toronto)
Perry, T. F. (1990) · VTechWorks (Virginia Tech)
Somatostatin Receptor/G Protein Coupling Directs the Regulation of Effector Systems
Law, S. F. (1995) · Drug Information Journal · doi:10.1177/00928615950290s104
Could Antibiotics Be Therapeutic Agents in Alzheimer’s Disease?
Gómez, O., Pintado, C., Rodríguez-Pérez, M., & Burgos‐Ramos, E. (2019) · Frontiers in clinical drug research. Alzheimer disorders · doi:10.2174/9789811401893119080005
Exploring the Role of Somatostatin in the Pathogenesis of Alzheimer’s disease
Solarski, M. (2018) · TSpace (University of Toronto)
Calcium, AMPA/Kainate Receptors, and Selective Neurodegeneration
Weiss, J. H., Yin, H. Z., Carriedo, S. G., & Lu, Y. M. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0209-2_42
Biological Signatures of Disease in Neuro-Psychiatry as Inter-Theoretical Reduction
Stoyanov, D. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/156802662009200331084634
Perry, R. H., Perry, E. K., & Abel, C. (1990) · Presses Universitaires de France eBooks · doi:10.3917/puf.lamou.1990.01.0113
Diverse Effects of Arousal and Locomotion on Inhibitory and Excitatory Neurons in Auditory Cortex
Yavorska, I. (2020) · Scholars' Bank (University of Oregon)
Fornix stimulation, effects on hippocampal oscillations and memory in an AD mice model
Varela, E. V. (2020) · eScholarship@McGill (McGill) · doi:10.82308/18555
Values clarification in dental education.
Silberman, S., Cohen, L., & Runyon, H. L. (1979) · PubMed
Therapy of Alzheimer’s Dementia
Mecocci, P., Polidori, M. C., Cherubini, A., & Senin, U. (1998) · Springer eBooks · doi:10.1007/978-1-4899-1483-5_21
(1989) · Elsevier eBooks · doi:10.1016/b978-0-12-510310-7.50013-2
Knowles, S. J., Holter, M. C., Li, G., et al. (2023) · doi:10.7554/elife.88313.1.sa0
Hostetler, R. E. (2023) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.12253
(outdated draft) Somatostatin and the pathophysiology of Alzheimer’s diseasePreprint
Almeida, V. N. (2024) · Qeios · doi:10.32388/goy6dk.2
Saido, T. C. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-28979-8.00004-8
Lin, Y., Bai, Y., Martín‐Ávila, A., Li, W., Wu, X., Ziff, E. B., & Gan, W. (2025) · Cell Calcium · doi:10.1016/j.ceca.2025.103048
Neuropeptide Expression in Animal Disease Models
Hökfelt, T. G. M., Diez, M., Shi, T.-J. S., Koıstınaho, J., Games, D., Kahn, K., Sommer, B., Wiederhold, K., & Danner, S. (2002) · Advances in behavioral biology · doi:10.1007/978-0-306-47593-1_20
New Approaches to Alzheimer’s Disease: Neurotrophic Factors
Appel, S. H., & Ojika, K. (1985) · Springer eBooks · doi:10.1007/978-1-4612-5058-6_7
Lee, S. H., Bolshakov, V. Y., & Shen, J. (2021) · Figshare · doi:10.6084/m9.figshare.14676659
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614915
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614924
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614909
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614918
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614921
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614927
Kang, J., & Shen, J. (2020) · Figshare · doi:10.6084/m9.figshare.13364319
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614906
Jang, J., Yeo, S., Baek, S., Jung, H. J., Lee, M. S., Choi, S. H., & Choe, Y. (2024) · Figshare · doi:10.6084/m9.figshare.26614912
Somatostatin Neurons in Prefrontal Cortical Microcircuits in Schizophrenia
Dienel, S. J. (2023) · D-Scholarship@Pitt (University of Pittsburgh)
Johnson, S. T. (2022) · University of Minnesota Digital Conservancy (University of Minnesota)
Astrocytic neurotransmitter receptors (astro‑glioreceptors) and their role in neuroplasticity
Liguz‐Lecznar, M., & Kossut, M. M. (2025) · Acta Neurobiologiae Experimentalis · doi:10.55782/esvr6218
“In Alzheimer’s disease, somatostatin‑pos‑ itive interneurons are particularly vulnerable to de‑ generation, and somatostatin levels are significantly reduced in affected brain regions (Davies et al., 1980).”
Selective Lis1 inactivation disrupts migration and positioning of cortical somatostatin interneurons
Pombero, A., García-López, R., Geijo‐Barrientos, E., & Martínez, S. (2026) · Scientific Reports · doi:10.1038/s41598-026-38316-x
“…to a decrease in the number of SST+ interneurons in several neurodegenerative disorders, such as a reduction in the frontal cortex and hippocampus in Alzheimer’s disease 60,61 , in the cortex in Parkinson’s disease 62 , in the striatum in Huntington’s disease 63 and in the hippocampus in SCZ 64 .”
Implications of cellular changes in depression on human cortical microcircuit activity
Yao, H. K. (2025) · TSpace (University of Toronto)
Yan, B. Q. (2022) · TSpace (University of Toronto)
Rey, C. C. (2020) · theses.fr (ABES) · doi:10.70675/4bc74e03zfa3az49e6zb5aaz35059441853a · Cited by 1
Altered neuronal activity in the hippocampal CA3 region in an in vitro model of tauopathy
Goncalves, A. (2020) · theses.fr (ABES) · doi:10.70675/b42db6dez88a0z4a14z93eez8f51d19d46f5
Behl, C. (2026) · Springer eBooks · doi:10.1007/978-3-662-72210-7_5
Kasprzak, A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27104244
Somatostatin regulation of the stress response
Guo, H., Ali, T., & Li, S. (2026) · Brain medicine : · doi:10.61373/bm026i.0042
Yang, M., Ouyang, X., Gautam, S., Singleton, M., Davydzenka, V., Zhang, J., & Li, Y. (2026) · Molecular Brain · doi:10.1186/s13041-026-01332-z
“SST-positive interneurons are perhaps among the earliest detected cell types with a severe loss and the most vulnerable neuronal populations in AD [7–9, 11, 12].”
Somatostatin: A crossroad between pancreatic and neural pathways
Rahmanian, M., Gharajeh, S. E., Zahedi, A., Gharedaghi, H., Abbasian, H., & Kamali, M. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-30263-3.00022-1
Lee, E. J., Bae, S., Suh, M., Choi, H., Choi, Y., Hwang, D. W., & Lee, D. S. (2024) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.10404411
Metadata
- Authors
- Davies, P., Katzman, R., & Terry, R. D.
- Affiliations
- Albert Einstein College of Medicine (US)
- Venue
- Nature
- Published
- 1980-11
- Volume
- 288
- Issue
- 5788
- Pages
- 279-280
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2034969383
- Cited by
- 882
- References
- 9
- Citations by year
- 2026: 6 · 2025: 12 · 2024: 20 · 2023: 18 · 2022: 11 · 2021: 11 · 2020: 19 · 2019: 8 · 2018: 9 · 2017: 5 · 2016: 7 · 2015: 7 · 2014: 7 · 2013: 9 · 2012: 8
- FWCI
- 25.37
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- Alzheimer's disease, senile dementia of the Alzheimer type, somatostatin, somatostatin-like immunoreactivity, cerebral cortex, neuropeptides, peptidergic neurons, neurotransmitter systems, cholinergic neurons, neurofibrillary tangles, neuritic plaques
- MeSH terms
- Aged, Alzheimer Disease, Cerebral Cortex, Choline O-Acetyltransferase, Dementia, Humans, Middle Aged, Radioimmunoassay, Somatostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.